Diversity and composition of gut microbiota in healthy individuals and patients at different stages of hepatitis B virus-related liver disease

[1]  H. Tilg,et al.  Gut-liver axis: Pathophysiological concepts and clinical implications. , 2022, Cell metabolism.

[2]  A. Kurilshikov,et al.  Environmental factors shaping the gut microbiome in a Dutch population , 2022, Nature.

[3]  W. Shu,et al.  Gut microbiota dysbiosis in patients with hepatitis B virus-related cirrhosis. , 2022, Annals of hepatology.

[4]  A. Gasbarrini,et al.  Fecal Microbiota Transplantation in Patients with HBV Infection or Other Chronic Liver Diseases: Update on Current Knowledge and Future Perspectives , 2021, Journal of clinical medicine.

[5]  Hang Zhou,et al.  The diagnostic potential of gut microbiome for early hepatitis B virus-related hepatocellular carcinoma , 2020, European journal of gastroenterology & hepatology.

[6]  Chang-qing Yang,et al.  Effect of Entecavir on the Intestinal Microflora in Patients with Chronic Hepatitis B: A Controlled Cross-Sectional and Longitudinal Real-World Study , 2020, Infectious Diseases and Therapy.

[7]  Zhishuo Mo,et al.  Potential role of intestinal microflora in disease progression among patients with different stages of Hepatitis B , 2020, Gut Pathogens.

[8]  Huiping Yuan,et al.  Gut bacteria Akkermansia is associated with reduced risk of obesity: evidence from the American Gut Project , 2020, Nutrition & Metabolism.

[9]  K. Verbeke,et al.  Short chain fatty acids in human gut and metabolic health. , 2020, Beneficial microbes.

[10]  Gavin M Douglas,et al.  PICRUSt2 for prediction of metagenome functions , 2020, Nature Biotechnology.

[11]  Yuhuan Li,et al.  Entecavir Therapy Reverses Gut Microbiota Dysbiosis Induced by Hepatitis B Virus Infection in a Mouse Model. , 2020, International journal of antimicrobial agents.

[12]  Robert D. Stedtfeld,et al.  Featured Gut Microbiomes Associated With the Progression of Chronic Hepatitis B Disease , 2020, Frontiers in Microbiology.

[13]  A. de Gottardi,et al.  The gut-liver axis in liver disease: pathophysiological basis for therapy. , 2020, Journal of hepatology.

[14]  Q. Ou,et al.  Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma , 2020, Journal of viral hepatitis.

[15]  A. Sanyal,et al.  THE ROLE OF THE GUT MICROBIOTA IN LIVER DISEASE. , 2020, American journal of physiology. Gastrointestinal and liver physiology.

[16]  Xue-Fang Peng,et al.  The intestinal microbial community dissimilarity in hepatitis B virus-related liver cirrhosis patients with and without at alcohol consumption , 2019, Gut Pathogens.

[17]  William A. Walters,et al.  Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2 , 2019, Nature Biotechnology.

[18]  E. Chuang,et al.  Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease , 2019, Journal of Neuroinflammation.

[19]  Ting Zhang,et al.  Akkermansia muciniphila is a promising probiotic , 2019, Microbial biotechnology.

[20]  Austin D. Swafford,et al.  Age- and Sex-Dependent Patterns of Gut Microbial Diversity in Human Adults , 2019, mSystems.

[21]  Yewei Zhang,et al.  Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma , 2019, Gut Pathogens.

[22]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2019, Clinical Liver Disease.

[23]  M. Abecassis,et al.  Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases , 2018, Hepatology.

[24]  Justine W. Debelius,et al.  The gut–liver axis and the intersection with the microbiome , 2018, Nature Reviews Gastroenterology & Hepatology.

[25]  Ding‐Shinn Chen,et al.  Acoustic Radiation Force Impulse US Imaging: Liver Stiffness in Patients with Chronic Hepatitis B with and without Antiviral Therapy. , 2018, Radiology.

[26]  Paul J. McMurdie,et al.  DADA2: High resolution sample inference from Illumina amplicon data , 2016, Nature Methods.

[27]  T. Karlsen,et al.  The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls , 2016, Gut.

[28]  R. Talukdar,et al.  Role of the normal gut microbiota. , 2015, World journal of gastroenterology.

[29]  E. Goldstein,et al.  Lactobacillus species: taxonomic complexity and controversial susceptibilities. , 2015, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  B. Autran,et al.  Towards an HBV cure: state-of-the-art and unresolved questions—report of the ANRS workshop on HBV cure , 2015, Gut.

[31]  W. D. de Vos,et al.  The first 1000 cultured species of the human gastrointestinal microbiota , 2014, FEMS microbiology reviews.

[32]  B. Chassaing,et al.  Microbiota‐liver axis in hepatic disease , 2014, Hepatology.

[33]  W. Liu,et al.  Abnormal fecal microbiota community and functions in patients with hepatitis B liver cirrhosis as revealed by a metagenomic approach , 2013, BMC Gastroenterology.

[34]  Susan Holmes,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[35]  Baoli Zhu,et al.  Characterization of fecal microbial communities in patients with liver cirrhosis , 2011, Hepatology.

[36]  C. Huttenhower,et al.  Metagenomic biomarker discovery and explanation , 2011, Genome Biology.

[37]  Wei Xu,et al.  Intestinal Microbiota Was Assessed in Cirrhotic Patients with Hepatitis B Virus Infection , 2011, Microbial Ecology.

[38]  Harry J. Flint,et al.  Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. , 2009, FEMS microbiology letters.

[39]  J. Söderholm,et al.  The role of microbiota and probiotics in stress-induced gastro-intestinal damage. , 2008, Current molecular medicine.

[40]  A. Plebani,et al.  Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL. , 2007, Immunity.

[41]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[42]  Susumu Goto,et al.  KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..